Method for prediction of therapeutic effect of chemotherapy employing expression level of dihydropyrimidine dehydrogenase gene as measure

• 收藏
• 分享

专利权人:

Toshinori Oka

发明人:

Toshinori Oka

申请号：

US13321202

公开号：

US08697681B2

申请日:

2010.05.21

申请国别(地区):

US

年份:

2014

代理人:

摘要：

The present invention provides an antitumor agent comprising cisplatin and a combination drug of tegafur/gimeracil/oteracil potassium that ensures an excellent life-prolongation effect in advanced gastric cancer patients that is superior to that of the standard therapy in Europe and the U.S. using an agent that contains 5-FU and does not contain a dihydropyrimidine dehydrogenase inhibitor, by way of selecting the patients based on dihydropyrimidine dehydrogenase.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/